Reagents and consumables

Ended Awarded

Contract number
75N91023F00009
Awardee
Awarding agency
Obligated
$24,367

Award facts

Contract value 100% obligated
$24,366.62 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Indianapolis, IN 46250, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

Roche Diagnostics Corporation was awarded a $24,366.62 firm fixed price delivery order for reagents and consumables by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute. The contract has no set-aside designation and requires performance in Castleton, Indiana, with completion by April 23, 2024. As the prime contractor, Roche Diagnostics will provide laboratory materials to support the National Cancer Institute's biomedical research efforts studying cancer prevention, diagnosis, and treatment.

Quick answers

Who was awarded contract 75N91023F00009?

75N91023F00009 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on March 23, 2023.

How much is contract 75N91023F00009 worth?

The government has obligated $24,367 on 75N91023F00009.

Is contract 75N91023F00009 an order under another contract?

Yes. 75N91023F00009 is a delivery order under 75N91019D00038, an indefinite delivery contract.

Was contract 75N91023F00009 competed?

The extent of competition for 75N91023F00009 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login